| 臺大學術典藏 |
2021-03-09T06:46:12Z |
Recent advances in the treatment of nasopharyngeal carcinoma
|
Chang J.T.-C.;Ko J.-Y.;Ruey-Long Hong; Chang J.T.-C.; Ko J.-Y.; RUEY-LONG HONG |
| 臺大學術典藏 |
2021-03-09T06:46:11Z |
Unexpected rapid progression of metastatic adenoid cystic carcinoma during treatment with imatinib mesylate
|
Lin C.-H.;Yen R.-F.;Jeng Y.-M.;Tzen C.-Y.;Hsu C.;Ruey-Long Hong; Lin C.-H.; Yen R.-F.; Jeng Y.-M.; Tzen C.-Y.; Hsu C.; RUEY-LONG HONG |
| 臺大學術典藏 |
2021-03-09T06:46:11Z |
Multicenter, phase II study of cetuximab in combination with carboplatin in patients with recurrent or metastatic nasopharyngeal carcinoma
|
Chan A.T.C.;Hsu M.-M.;Goh B.C.;Hui E.P.;Liu T.-W.;Millward M.J.;Ruey-Long Hong;Whang-Peng J.;Ma B.B.Y.;To K.F.;Mueser M.;Amellal N.;Lin X.;Chang A.Y.; Chan A.T.C.; Hsu M.-M.; Goh B.C.; Hui E.P.; Liu T.-W.; Millward M.J.; RUEY-LONG HONG; Whang-Peng J.; Ma B.B.Y.; To K.F.; Mueser M.; Amellal N.; Lin X.; Chang A.Y. |
| 臺大學術典藏 |
2021-03-09T06:46:11Z |
Early restaging whole-body 18F-FDG PET during induction chemotherapy predicts clinical outcome in patients with locoregionally advanced nasopharyngeal carcinoma
|
Yen R.-F.;Chen T.H.-H.;Ting L.-L.;Tzen K.-Y.;Pan M.-H.;Ruey-Long Hong; Yen R.-F.; Chen T.H.-H.; Ting L.-L.; Tzen K.-Y.; Pan M.-H.; RUEY-LONG HONG |
| 臺大學術典藏 |
2021-03-09T06:46:10Z |
Phase II study of gemcitabine plus vinorelbine in the treatment of cisplatin-resistant nasopharyngeal carcinoma
|
Wang C.-C.;Chang J.-Y.;Liu T.-W.;Lin C.-Y.;Yu Y.-C.;Ruey-Long Hong; Wang C.-C.; Chang J.-Y.; Liu T.-W.; Lin C.-Y.; Yu Y.-C.; RUEY-LONG HONG |
| 臺大學術典藏 |
2021-03-09T06:46:10Z |
Response of refractory osteosarcoma to thalidomide and celecoxib
|
Tsai Y.-C.;Wu C.-T.;Ruey-Long Hong; Tsai Y.-C.; Wu C.-T.; RUEY-LONG HONG |
| 臺大學術典藏 |
2021-03-09T06:46:10Z |
Whole-body 18F-FDG PET in recurrent or metastatic nasopharyngeal carcinoma
|
Yen R.-F.;Ruey-Long Hong;Tzen K.-Y.;Pan M.-H.;Chen T.H.-H.; Yen R.-F.; RUEY-LONG HONG; Tzen K.-Y.; Pan M.-H.; Chen T.H.-H. |
| 臺大學術典藏 |
2021-03-09T06:46:10Z |
Difference in the incidence trend of nasopharyngeal and oropharyngeal carcinomas in Taiwan: Implication from age-period-cohort analysis
|
Hsu C.;Shen Y.-C.;Cheng C.-C.;Ruey-Long Hong;Chang C.-J.;Cheng A.-L.; Hsu C.; Shen Y.-C.; Cheng C.-C.; RUEY-LONG HONG; Chang C.-J.; Cheng A.-L. |
| 臺大學術典藏 |
2021-03-09T06:46:09Z |
The Cost-utility Analysis of 18-Fluoro-2-Deoxyglucose Positron Emission Tomography in the Diagnosis of Recurrent Nasopharyngeal Carcinoma
|
Yen R.-F.; Yen M.-F.; RUEY-LONG HONG; Tzen K.-Y.; Chien C.-R.; Chen T.H.-H. |
| 臺大學術典藏 |
2021-03-09T06:46:09Z |
A phase-I study evaluating the combination of pegylated liposomal doxorubicin and paclitaxel as salvage chemotherapy in metastatic breast cancer previously treated with anthracycline
|
Ruey-Long Hong;Lin C.-H.;Chao T.-Y.;Kao W.-Y.;Wang C.-H.;Hsieh R.K.;Hwang W.-S.; RUEY-LONG HONG; Lin C.-H.; Chao T.-Y.; Kao W.-Y.; Wang C.-H.; Hsieh R.K.; Hwang W.-S. |
| 臺大學術典藏 |
2021-03-09T06:46:09Z |
Fatal thrombocytopenia after oxaliplatin-based chemotherapy
|
Shao Y.-Y.; RUEY-LONG HONG |
| 臺大學術典藏 |
2021-03-09T06:46:08Z |
Pleural metastases as a unique entity with dismal outcome of head and neck squamous cell carcinoma
|
Shao Y.-Y.;Ruey-Long Hong; Shao Y.-Y.; RUEY-LONG HONG |
| 臺大學術典藏 |
2021-03-09T06:46:08Z |
The diagnostic and prognostic effectiveness of F-18 sodium fluoride PET-CT in detecting bone metastases for hepatocellular carcinoma patients
|
Yen R.-F.;Chen C.-Y.;Cheng M.-F.;Wu Y.-W.;Shiau Y.-C.;Wu K.;Ruey-Long Hong;Yu C.-J.;Wang K.-L.;Yang R.-S.; Yen R.-F.; Chen C.-Y.; Cheng M.-F.; Wu Y.-W.; Shiau Y.-C.; Wu K.; RUEY-LONG HONG; Yu C.-J.; Wang K.-L.; Yang R.-S. |
| 臺大學術典藏 |
2021-03-09T06:46:08Z |
Usefulness of 201Tl spect/CT relative to 18F-FDG PET/CT in detecting recurrent skull base nasopharyngeal carcinoma
|
Yen R.-F.; Ting L.-L.; Cheng M.-F.; Wu Y.-W.; Tzen K.-Y.; RUEY-LONG HONG |
| 臺大學術典藏 |
2021-03-09T06:46:08Z |
Nasion swelling as the presenting symptom of lung adenocarcinoma
|
Huang C.-T.; RUEY-LONG HONG |
| 臺大學術典藏 |
2021-03-09T06:46:07Z |
Clinicopathological features of salivary and non-salivary adenoid cystic carcinomas
|
Lin Y.-C.; Chen K.-C.; Lin C.-H.; Kuo K.-T.; Ko J.-Y.; RUEY-LONG HONG |
| 臺大學術典藏 |
2021-03-09T06:46:07Z |
Postoperative intensity-modulated radiotherapy for squamous cell carcinoma of the external auditory canal and middle ear: Treatment outcomes, marginal misses, and perspective on target delineation
|
Chen W.-Y.; Kuo S.-H.; Chen Y.-H.; Lu S.-H.; Tsai C.-L.; Chia-Hsien Cheng J.; RUEY-LONG HONG; Chen Y.-F.; Hsu C.-J.; Lin K.-N.; Ko J.-Y.; Lou P.-J.; Wang C.-P.; Chong F.-C.; Wang C.-W. |
| 臺大學術典藏 |
2021-03-09T06:46:07Z |
A phase I and pharmacokinetic study of liposomal vinorelbine in patients with advanced solid tumor
|
Yang S.-H.; Lin C.-C.; Lin Z.-Z.; Tseng Y.-L.; RUEY-LONG HONG |
| 臺大學術典藏 |
2021-03-09T06:46:06Z |
Phase II trial of capecitabine plus cisplatin as first-line therapy in patients with metastatic nasopharyngeal cancer
|
Chua D.T.T.; Yiu H.H.-Y.; Seetalarom K.; Ng A.W.-Y.; Kurnianda J.; Shotelersuk K.; Krishnan G.; RUEY-LONG HONG; Yang M.-H.; Wang C.-H.; Sze W.-K.; Ng W.-T. |
| 臺大學術典藏 |
2021-03-09T06:46:06Z |
Osteoradionecrosis of the upper cervical spine after radiation therapy for head and neck cancer: Differentiation from recurrent or metastatic disease with MR imaging
|
Wu L.-A.;Liu H.-M.;Wang C.-W.;Chen Y.-F.;Ruey-Long Hong;Ko J.-Y.; Wu L.-A.; Liu H.-M.; Wang C.-W.; Chen Y.-F.; RUEY-LONG HONG; Ko J.-Y. |
| 臺大學術典藏 |
2021-03-09T06:46:06Z |
Factors impacting prognosis prediction in BCLC stage C and Child-Pugh Class A hepatocellular carcinoma patients in prospective clinical trials of systemic therapy
|
Lin Z.-Z.; Hsu C.; Hu F.-C.; Shao Y.-Y.; Chang D.-Y.; Yang C.-H.; RUEY-LONG HONG; Hsu C.-H.; Chengb A.-L. |
| 臺大學術典藏 |
2021-03-09T06:46:05Z |
An international collaboration to harmonize the quantitative plasma Epstein-Barr virus DNA assay for future biomarker-guided trials in nasopharyngeal carcinoma
|
Le Q.-T.; Zhang Q.; Cao H.; Cheng A.-J.; Pinsky B.A.; RUEY-LONG HONG; Chang J.T.; Wang C.-W.; Tsao K.-C.; Lo Y.M.D.; Lee N.; Ang K.K.; Chan A.T.C.; Chan K.C.A. |
| 臺大學術典藏 |
2021-03-09T06:46:05Z |
Intensity-modulated radiation therapy for T4 nasopharyngeal carcinoma: Treatment results and locoregional recurrence
|
Chen J.L.-Y.; Huang Y.-S.; Kuo S.-H.; Chen Y.-F.; RUEY-LONG HONG; Ko J.-Y.; Lou P.-J.; Tsai C.-L.; Chen W.-Y.; Wang C.-W. |
| 臺大學術典藏 |
2021-03-09T06:46:05Z |
Pemetrexed in combination with cisplatin versus cisplatin monotherapy in patients with recurrent or metastatic head and neck cancer: Final results of a randomized, double-blind, placebo-controlled, phase 3 study
|
Urba S.; Van Herpen C.M.L.; Sahoo T.P.; Shin D.M.; Licitra L.; Mezei K.; Reuter C.; Hitt R.; Russo F.; Chang S.-C.; Hossain A.M.; Frimodt-Moller B.; Koustenis A.; RUEY-LONG HONG |
| 臺大學術典藏 |
2021-03-09T06:46:05Z |
Identification of novel mutations of TP53, ALK and RET gene in metastatic thymic squamous cell carcinoma and its therapeutic implication
|
Hu Z.; Wang J.; Yao T.; RUEY-LONG HONG; Zhang K.; Gao H.; Wu X.; Li J.; Bai C.; Yen Y. |
| 臺大學術典藏 |
2021-03-09T06:46:04Z |
�\-Enolase-binding peptide enhances drug delivery efficiency and therapeutic efficacy against colorectal cancer
|
Wu C.-H.;Kuo Y.-H.;Ruey-Long Hong;Wu H.-C.; Wu C.-H.; Kuo Y.-H.; RUEY-LONG HONG; Wu H.-C. |
| 臺大學術典藏 |
2021-03-09T06:46:04Z |
Dual-effect liposomes encapsulated with doxorubicin and chlorin e6 augment the therapeutic effect of tumor treatment
|
Peng P.-C.;Ruey-Long Hong;Tsai Y.-J.;Li P.-T.;Tsai T.;Chen C.-T.; Peng P.-C.; RUEY-LONG HONG; Tsai Y.-J.; Li P.-T.; Tsai T.; Chen C.-T. |
| 臺大學術典藏 |
2021-03-09T06:46:04Z |
Pemetrexed in combination with cisplatin versus cisplatin monotherapy in East Asian patients with recurrent or metastatic head and neck cancer: Results of an exploratory subgroup analysis of a phase III trial
|
Urba S.; RUEY-LONG HONG; Hossain A.M.; Cheng R.; Orlando M. |
| 臺大學術典藏 |
2021-03-09T06:46:03Z |
Intensity-modulated radiation therapy achieves better local control compared to three-dimensional conformal radiation therapy for T4-stage nasopharyngeal carcinoma
|
Chen J.L.;Huang Y.-S.;Kuo S.-H.;Ruey-Long Hong;Ko J.-Y.;Lou P.-J.;Wang C.-W.; Chen J.L.; Huang Y.-S.; Kuo S.-H.; RUEY-LONG HONG; Ko J.-Y.; Lou P.-J.; Wang C.-W. |
| 臺大學術典藏 |
2021-03-09T06:46:03Z |
Treatment outcomes of and prognostic factors for definitive radiotherapy with and without chemotherapy for Stage I/II nasal extranodal NK/T-cell lymphoma
|
Yang C.W.-C.;Wang C.-W.;Ruey-Long Hong;Tsai C.-L.;Yao M.;Tang J.-L.;Lin C.-W.;Cheng A.-L.;Kuo S.-H.; Yang C.W.-C.; Wang C.-W.; RUEY-LONG HONG; Tsai C.-L.; Yao M.; Tang J.-L.; Lin C.-W.; Cheng A.-L.; Kuo S.-H. |
| 臺大學術典藏 |
2021-03-09T06:46:03Z |
Histone methyltransferase G9a drives chemotherapy resistance by regulating the glutamate�Vcysteine ligase catalytic subunit in head and neck squamous cell carcinoma
|
Liu C.-W.;Hua K.-T.;Li K.-C.;Kao H.-F.;Ruey-Long Hong;Ko J.-Y.;Hsiao M.;Kuo M.-L.;Tan C.-T.; Liu C.-W.; Hua K.-T.; Li K.-C.; Kao H.-F.; RUEY-LONG HONG; Ko J.-Y.; Hsiao M.; Kuo M.-L.; Tan C.-T. |
| 臺大學術典藏 |
2021-03-09T06:46:02Z |
A randomized, open-label, Phase III clinical trial of nivolumab vs. therapy of investigator's choice in recurrent squamous cell carcinoma of the head and neck: A subanalysis of Asian patients versus the global population in checkmate 141
|
Kiyota N.;Hasegawa Y.;Takahashi S.;Yokota T.;Yen C.-J.;Iwae S.;Shimizu Y.;Ruey-Long Hong;Goto M.;Kang J.-H.;Sum Kenneth Li W.;Ferris R.L.;Gillison M.;Namba Y.;Monga M.;Lynch M.;Tahara M.; Kiyota N.; Hasegawa Y.; Takahashi S.; Yokota T.; Yen C.-J.; Iwae S.; Shimizu Y.; RUEY-LONG HONG; Goto M.; Kang J.-H.; Sum Kenneth Li W.; Ferris R.L.; Gillison M.; Namba Y.; Monga M.; Lynch M.; Tahara M. |
| 臺大學術典藏 |
2021-03-09T06:46:02Z |
Pembrolizumab for the treatment of advanced salivary gland carcinoma
|
Cohen R.B.;Delord J.-P.;Doi T.;Piha-Paul S.A.;Liu S.V.;Gilbert J.;Algazi A.P.;Damian S.;Ruey-Long Hong;Le Tourneau C.;Day D.;Varga A.;Elez E.;Wallmark J.;Saraf S.;Thanigaimani P.;Cheng J.;Keam B.; Cohen R.B.; Delord J.-P.; Doi T.; Piha-Paul S.A.; Liu S.V.; Gilbert J.; Algazi A.P.; Damian S.; RUEY-LONG HONG; Le Tourneau C.; Day D.; Varga A.; Elez E.; Wallmark J.; Saraf S.; Thanigaimani P.; Cheng J.; Keam B. |
| 臺大學術典藏 |
2021-03-09T06:46:02Z |
Final results of a randomized phase III trial of induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in patients with stage IVA and IVB nasopharyngeal carcinoma-Taiwan Cooperative Oncology Group (TCOG) 1303 Study
|
Ruey-Long Hong;Hsiao C.F.;Ting L.L.;Ko J.Y.;Wang C.W.;Chang J.T.C.;Lou P.J.;Wang H.M.;Tsai M.H.;Lai S.C.;Liu T.W.; RUEY-LONG HONG; Hsiao C.F.; Ting L.L.; Ko J.Y.; Wang C.W.; Chang J.T.C.; Lou P.J.; Wang H.M.; Tsai M.H.; Lai S.C.; Liu T.W. |
| 臺大學術典藏 |
2021-03-09T06:46:02Z |
Terminally Ill Taiwanese Cancer Patients�� and Family Caregivers�� Agreement on Patterns of Life-Sustaining Treatment Preferences Is Poor to Fair and Declines Over a Decade: Results From Two Independent Cross-Sectional Studies
|
Liu T.-W.;Wen F.-H.;Wang C.-H.;Ruey-Long Hong;Chow J.-M.;Chen J.-S.;Chiu C.-F.;Tang S.T.; Liu T.-W.; Wen F.-H.; Wang C.-H.; RUEY-LONG HONG; Chow J.-M.; Chen J.-S.; Chiu C.-F.; Tang S.T. |
| 臺大學術典藏 |
2021-03-09T06:46:01Z |
Prognostic factors and treatment outcomes of adult patients with rhabdomyosarcoma after multimodality treatment
|
Liu Y.-T.;Wang C.-W.;Ruey-Long Hong;Kuo S.-H.; Liu Y.-T.; Wang C.-W.; RUEY-LONG HONG; Kuo S.-H. |
| 臺大學術典藏 |
2021-03-09T06:46:01Z |
A High-Throughput Immune-Oncology Screen Identifies EGFR Inhibitors as Potent Enhancers of Antigen-Specific Cytotoxic T-lymphocyte Tumor Cell Killing
|
Lizotte P.H.;Ruey-Long Hong;Luster T.A.;Cavanaugh M.E.;Taus L.J.;Wang S.;Dhaneshwar A.;Mayman N.;Yang A.;Kulkarni M.;Badalucco L.;Fitzpatrick E.;Kao H.-F.;Kuraguchi M.;Bittinger M.;Kirschmeier P.T.;Gray N.S.;Barbie D.A.;Janne P.A.; Lizotte P.H.; RUEY-LONG HONG; Luster T.A.; Cavanaugh M.E.; Taus L.J.; Wang S.; Dhaneshwar A.; Mayman N.; Yang A.; Kulkarni M.; Badalucco L.; Fitzpatrick E.; Kao H.-F.; Kuraguchi M.; Bittinger M.; Kirschmeier P.T.; Gray N.S.; Barbie D.A.; Janne P.A. |
| 臺大學術典藏 |
2021-03-09T06:46:00Z |
Co-encapsulation of chlorin e6 and chemotherapeutic drugs in a pegylated liposome enhance the efficacy of tumor treatment: Pharmacokinetics and therapeutic efficacy
|
Peng P.-C.;Ruey-Long Hong;Tsai T.;Chen C.-T.; Peng P.-C.; RUEY-LONG HONG; Tsai T.; Chen C.-T. |
| 臺大學術典藏 |
2021-03-09T06:46:00Z |
Primary intradural extramedullary spinal mesenchymal chondrosarcoma: Case report and literature review
|
Chen C.-W.;Chen I.-H.;Hu M.-H.;Lee J.-C.;Huang H.-Y.;Ruey-Long Hong;Yang S.-H.; Chen C.-W.; Chen I.-H.; Hu M.-H.; Lee J.-C.; Huang H.-Y.; RUEY-LONG HONG; Yang S.-H. |
| 臺大學術典藏 |
2021-03-09T06:45:59Z |
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
|
Burtness B.;Harrington K.J.;Greil R.;Souli?Res D.;Tahara M.;De Castro G.;Jr, Psyrri A.;Bast? N.;Neupane P.;Bratland ?.;Fuereder T.;Hughes B.G.M.;Mes?A R.;Ngamphaiboon N.;Rordorf T.;Wan Ishak W.Z.;Ruey-Long Hong;Gonz?Lez Mendoza R.;Roy A.;Zhang Y.;Gumuscu B.;Cheng J.D.;Jin F.;Rischin D.;Lerzo G.;Tatangelo M.;Varela M.;Zarba J.J.;Boyer M.;Gan H.;Gao B.;Hughes B.;Mallesara G.;Taylor A.;Burian M.;Barrios C.H.;De Castro Junior D.O.;Castro G.;Franke F.A.;Girotto G.;Lima I.P.F.;Nicolau U.R.;Pinto G.D.J.;Santos L.;Victorino A.-P.;Chua N.;Couture F.;Gregg R.;Hansen A.;Hilton J.;Mccarthy J.;Soulieres D.;Ascui R.;Gonzalez P.;Villanueva L.;Torregroza M.;Zambrano A.;Holeckova P.;Kral Z.;Melichar B.;Prausova J.;Vosmik M.;Andersen M.;Gyldenkerne N.;Jurgens H.;Putnik K.;Reinikainen P.;Gruenwald V.;Laban S.;Aravantinos G.;Boukovinas I.;Georgoulias V.;Kwong D.;Al-Farhat Y.;Csoszi T.;Erfan J.;Horvai G.;Landherr L.;Remenar E.;Ruzsa A.;Szota J.;Billan S.;Gluck I.;Gutfeld O.;Popovtzer A.;Benasso M.;Bui S.;Ferrari V.;Licitra L.;Nole F.;Fujii T.;Fujimoto Y.;Hanai N.;Hara H.;Matsumoto K.;Mitsugi K.;Monden N.;Nakayama M.;Okami K.;Oridate N.;Shiga K.;Shimizu Y.;Sugasawa M.;Takahashi M.;Takahashi S.;Tanaka K.;Ueda T.;Yamaguchi H.;Yamazaki T.;Yasumatsu R.;Yokota T.;Yoshizaki T.;Kudaba I.;Stara Z.;Cheah S.K.;Aguilar Ponce J.;Gonzalez Mendoza R.;Hernandez Hernandez C.;Medina Soto F.;Buter J.;Hoeben A.;Oosting S.;Suijkerbuijk K.;Bratland A.;Brydoey M.;Alvarez R.;Mas L.;Caguioa P.;Querol J.;Regala E.E.;Tamayo M.B.;Villegas E.M.;Kawecki A.;Karpenko A.;Klochikhin A.;Smolin A.;Zarubenkov O.;Goh B.C.;Cohen G.;Du Toit J.;Jordaan C.;Landers G.;Ruff P.;Szpak W.;Tabane N.;Brana I.;Iglesias Docampo L.;Lavernia J.;Mesia R.;Abel E.;Muratidu V.;Nielsen N.;Cristina V.;Rothschild S.;Wang H.-M.;Yang M.-H.;Yeh S.-P.;Yen C.-J.;Soparattanapaisarn N.;Sriuranpong V.;Aksoy S.;Cicin I.;Ekenel M.;Harputluoglu H.;Ozyilkan O.;Harrington K.;Agarwala S.;Ali H.;Alter R.;Anderson D.;Bruce J.;Campbell N.;Conde M.;Deeken J.;Edenfield W.;Feldman L.;Gaughan E.;Goueli B.;Halmos B.;Hegde U.;Hunis B.;Jotte R.;Karnad A.;Khan S.;Laudi N.;Laux D.;Martincic D.;Mccune S.;Mcgaughey D.;Misiukiewicz K.;Mulford D.;Nadler E.;Nunnink J.;Ohr J.;O'Malley M.;Patson B.;Paul D.;Popa E.;Powell S.;Redman R.;Rella V.;Rocha Lima C.;Sivapiragasam A.;Su Y.;Sukari A.;Wong S.;Yilmaz E.;Yorio J.; Burtness B.; Harrington K.J.; Greil R.; Souli?res D.; Tahara M.; de Castro G.; Jr, Psyrri A.; Bast? N.; Neupane P.; Bratland ?.; Fuereder T.; Hughes B.G.M.; Mes?a R.; Ngamphaiboon N.; Rordorf T.; Wan Ishak W.Z.; RUEY-LONG HONG; Gonz?lez Mendoza R.; Roy A.; Zhang Y.; Gumuscu B.; Cheng J.D.; Jin F.; Rischin D.; Lerzo G.; Tatangelo M.; Varela M.; Zarba J.J.; Boyer M.; Gan H.; Gao B.; Hughes B.; Mallesara G.; Taylor A.; Burian M.; Barrios C.H.; de Castro Junior D.O.; Castro G.; Franke F.A.; Girotto G.; Lima I.P.F.; Nicolau U.R.; Pinto G.D.J.; Santos L.; Victorino A.-P.; Chua N.; Couture F.; Gregg R.; Hansen A.; Hilton J.; McCarthy J.; Soulieres D.; Ascui R.; Gonzalez P.; Villanueva L.; Torregroza M.; Zambrano A.; Holeckova P.; Kral Z.; Melichar B.; Prausova J.; Vosmik M.; Andersen M.; Gyldenkerne N.; Jurgens H.; Putnik K.; Reinikainen P.; Gruenwald V.; Laban S.; Aravantinos G.; Boukovinas I.; Georgoulias V.; Kwong D.; Al-Farhat Y.; Csoszi T.; Erfan J.; Horvai G.; Landherr L.; Remenar E.; Ruzsa A.; Szota J.; Billan S.; Gluck I.; Gutfeld O.; Popovtzer A.; Benasso M.; Bui S.; Ferrari V.; Licitra L.; Nole F.; Fujii T.; Fujimoto Y.; Hanai N.; Hara H.; Matsumoto K.; Mitsugi K.; Monden N.; Nakayama M.; Okami K.; Oridate N.; Shiga K.; Shimizu Y.; Sugasawa M.; Takahashi M.; Takahashi S.; Tanaka K.; Ueda T.; Yamaguchi H.; Yamazaki T.; Yasumatsu R.; Yokota T.; Yoshizaki T.; Kudaba I.; Stara Z.; Cheah S.K.; Aguilar Ponce J.; Gonzalez Mendoza R.; Hernandez Hernandez C.; Medina Soto F.; Buter J.; Hoeben A.; Oosting S.; Suijkerbuijk K.; Bratland A.; Brydoey M.; Alvarez R.; Mas L.; Caguioa P.; Querol J.; Regala E.E.; Tamayo M.B.; Villegas E.M.; Kawecki A.; Karpenko A.; Klochikhin A.; Smolin A.; Zarubenkov O.; Goh B.C.; Cohen G.; du Toit J.; Jordaan C.; Landers G.; Ruff P.; Szpak W.; Tabane N.; Brana I.; Iglesias Docampo L.; Lavernia J.; Mesia R.; Abel E.; Muratidu V.; Nielsen N.; Cristina V.; Rothschild S.; Wang H.-M.; Yang M.-H.; Yeh S.-P.; Yen C.-J.; Soparattanapaisarn N.; Sriuranpong V.; Aksoy S.; Cicin I.; Ekenel M.; Harputluoglu H.; Ozyilkan O.; Harrington K.; Agarwala S.; Ali H.; Alter R.; Anderson D.; Bruce J.; Campbell N.; Conde M.; Deeken J.; Edenfield W.; Feldman L.; Gaughan E.; Goueli B.; Halmos B.; Hegde U.; Hunis B.; Jotte R.; Karnad A.; Khan S.; Laudi N.; Laux D.; Martincic D.; McCune S.; McGaughey D.; Misiukiewicz K.; Mulford D.; Nadler E.; Nunnink J.; Ohr J.; O'Malley M.; Patson B.; Paul D.; Popa E.; Powell S.; Redman R.; Rella V.; Rocha Lima C.; Sivapiragasam A.; Su Y.; Sukari A.; Wong S.; Yilmaz E.; Yorio J. |
| 臺大學術典藏 |
2021-03-09T06:45:59Z |
Two-year follow-up of a randomized phase III clinical trial of nivolumab vs. the investigator's choice of therapy in the Asian population for recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141)
|
Yen C.-J.; Kiyota N.; Hanai N.; Takahashi S.; Yokota T.; Iwae S.; Shimizu Y.; RUEY-LONG HONG; Goto M.; Kang J.-H.; Li W.S.K.; Ferris R.L.; Gillison M.; Endo T.; Jayaprakash V.; Tahara M. |
| 臺大學術典藏 |
2021-03-09T06:45:58Z |
The impacts of intra-arterial chemotherapy on head and neck microvascular reconstruction
|
Kuan C.-H.; Chung M.-J.; RUEY-LONG HONG; Tseng T.-Y.; Tai H.-C.; Cheng N.-C.; Hsieh J.-H.; Horng S.-Y.; Lai H.-S. |
| 臺大學術典藏 |
2020-02-13T09:53:56Z |
Co-Encapsulation of Chlorin e6 and Chemotherapeutic Drugs in a PEGylated Liposome Enhance the Efficacy of Tumor Treatment: Pharmacokinetics and Therapeutic Efficacy
|
CHIN-TIN CHEN;Tsuimin Tsai;Ruey-Long Hong;Po-Chun Peng; Po-Chun Peng; Ruey-Long Hong; Tsuimin Tsai; CHIN-TIN CHEN |
| 臺大學術典藏 |
2020-02-13T09:53:56Z |
Co-Encapsulation of Chlorin e6 and Chemotherapeutic Drugs in a PEGylated Liposome Enhance the Efficacy of Tumor Treatment: Pharmacokinetics and Therapeutic Efficacy
|
CHIN-TIN CHEN;Tsuimin Tsai;Ruey-Long Hong;Po-Chun Peng; Po-Chun Peng; Ruey-Long Hong; Tsuimin Tsai; CHIN-TIN CHEN |
| 臺大學術典藏 |
2018-09-10T05:01:39Z |
Effect of 5-aminolevulinic acid-mediated photodynamic therapy on MCF-7 and MCF-7/ADR cells.
|
Jui-Chang Tsai;Chin-Tin Chen;I-Fang Ling;Pei-Jen Lou;Jui-Chang Tsai;Ruey-Long Hong;Tsuimin Tsai;Jui-Chang Tsai; Tsuimin Tsai; Ruey-Long Hong; Jui-Chang Tsai; Pei-Jen Lou; I-Fang Ling; Chin-Tin Chen |
| 臺大學術典藏 |
2018-09-10T05:01:39Z |
Effect of 5-aminolevulinic acid-mediated photodynamic therapy on MCF-7 and MCF-7/ADR cells.
|
Jui-Chang Tsai;Chin-Tin Chen;I-Fang Ling;Pei-Jen Lou;Jui-Chang Tsai;Ruey-Long Hong;Tsuimin Tsai;Jui-Chang Tsai; Tsuimin Tsai; Ruey-Long Hong; Jui-Chang Tsai; Pei-Jen Lou; I-Fang Ling; Chin-Tin Chen |
| 臺大學術典藏 |
2018-09-10T03:52:53Z |
Lymphoma of Bone
|
Jwo-Luen Pao;Rong-Sen Yang;Ann-Lii Chen;Ruey-Long Hong;Chung-Wu Lin;Kai-Hsin Lin;Sheng-Mou Hou; RONG-SEN YANG |
